ANNX

Annexon, Inc.

Biotechnology · Biotechnology

$186.92 sample

-1.88 (-1.00%) 1D

Market cap

$1.08T

Price as of

2026-10-23

Latest filing

8-K · 2026-09-23

Alerts

8

Price$186.92 -5.51% 3M daily closessample

201.15186.92

2026-07-282026-08-192026-09-102026-10-012026-10-23

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 20INSInsider buy: General Counsel
Oct 14INSInsider buy: Chief Executive Officer
Oct 08INSInsider sell: Chief Executive Officer
Oct 05INSInsider sell: Chief Executive Officer
Sep 30INSInsider sell: Chief Executive Officer
Sep 23SEC8-K filed: material event
Sep 16SECDEF 14A filed
Sep 10SECDEF 14A filed

Sign up to see the real ANNX record →

Company facts

SEC EDGAR registration

Name: Annexon, Inc.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: -21sample, -100 to +100
Reporting currency: USD

Who is positioning in ANNX

sample

Insiders: 8 insider transactions over 90 days, net selling, $683.0M
Congress: 3 members traded over 90 days
Institutions · 13F: 25 funds hold $21.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$48.3B +13.1% y/y

Q4 2024Q3 2026

Inventory$27.8B +12.3% y/y

Q4 2024Q3 2026

Accounts receivable$21.7B +9.3% y/y

Q4 2024Q3 2026

Total debt$56.4B +13.3% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $336.8B -9.8% 3M
Sample peer B: $904.8B -0.2% 3M
Sample peer C: $108.3B -10.0% 3M
Sample peer D: $635.9B +10.0% 3M
Sample peer E: $686.9B -6.3% 3M